Three patient outcomes were measured in this new study: time to onset of ocular-related myasthenia gravis, Activities of ...

Medically reviewed by David Ozeri, MD Treatments for myasthenia gravis include medications to help control and prevent ...

Imagine having to consider your health and its limitations every single day. Often, we take our health for granted, but ...

The landscape of gMG treatment is rapidly evolving, said John Morren, MD, of the Cleveland Clinic. The traditional approach ...

Myasthenia Gravis is a long-term, autoimmune condition in which the communication between muscles and nerves is impaired due to the production of certain antibodies resulting in voluntary muscle ...

If a person happens to have myasthenia gravis, please consider being part of a clinical trial. Any type of participation by patients with this relatively rare disease is desired, ...

Overall, the cohorts had similar rates of visits to nonneurology specialists (myasthenia gravis cohort, 99.8%; control cohort, 96.4%), but overnight hospitalizations were approximately double in ...

Increased risk of co-existing autoimmune disease in myasthenia gravis patients. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2014 / 10 / 141030100527.htm ...

Patients with myasthenia gravis — particularly those post-thymectomy — demonstrate an increased odds for having systemic lupus erythematosus, according to a speaker at the 2021 North American ...

A 33-year-old woman was found to be HIV-infected and diagnosed with myasthenia gravis by a neurologist in 1999. She was treated with pyridostigmine (60 mg 5 times daily) but had a myasthenia ...

People with myasthenia gravis were at higher risk for severe cases of COVID-19, including infections leading to hospitalization and death, a Canadian population-based study showed.

A patient with myasthenia gravis was found to have a locally invasive thymoma, which could not be removed surgically. Subsequently, cryptococcal meningitis, which seemed to be successfully treated ...